WO2013100822A3 - Гемостимулирующее средство - Google Patents

Гемостимулирующее средство Download PDF

Info

Publication number
WO2013100822A3
WO2013100822A3 PCT/RU2012/001120 RU2012001120W WO2013100822A3 WO 2013100822 A3 WO2013100822 A3 WO 2013100822A3 RU 2012001120 W RU2012001120 W RU 2012001120W WO 2013100822 A3 WO2013100822 A3 WO 2013100822A3
Authority
WO
WIPO (PCT)
Prior art keywords
hemostimulating
agent
cysteinyl
glutamyl
glycine
Prior art date
Application number
PCT/RU2012/001120
Other languages
English (en)
French (fr)
Other versions
WO2013100822A2 (ru
Inventor
Марк Борисович БАЛАЗОВСКИЙ
Виктор Георгиевич АНТОНОВ
Олег Александрович ИГНАТЕНКО
Original Assignee
Общество С Ограниченной Ответственностью "Ива Фарм"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество С Ограниченной Ответственностью "Ива Фарм" filed Critical Общество С Ограниченной Ответственностью "Ива Фарм"
Publication of WO2013100822A2 publication Critical patent/WO2013100822A2/ru
Publication of WO2013100822A3 publication Critical patent/WO2013100822A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Согласно данному изобретению предложены комбинация бис-(γ-L-глутамил)-L-цистеинил-глицина дилитиевой соли и координационных соединений, образованных палладием, медью и (γ-L-глутамил)-L-цистеинил-глицином, содержащая такую комбинацию фармацевтическая композиция, а также способ стимулирования гемопоэза с их использованием.
PCT/RU2012/001120 2011-12-30 2012-12-27 Гемостимулирующее средство WO2013100822A2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2011154536/15A RU2482869C1 (ru) 2011-12-30 2011-12-30 Гемостимулирующее средство, фармацевтическая композиция и способ стимулирования гемопоэза
RU2011154536 2011-12-30

Publications (2)

Publication Number Publication Date
WO2013100822A2 WO2013100822A2 (ru) 2013-07-04
WO2013100822A3 true WO2013100822A3 (ru) 2013-09-26

Family

ID=48698768

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2012/001120 WO2013100822A2 (ru) 2011-12-30 2012-12-27 Гемостимулирующее средство

Country Status (2)

Country Link
RU (1) RU2482869C1 (ru)
WO (1) WO2013100822A2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019099753A1 (en) * 2017-11-15 2019-05-23 The Translational Genomics Research Institute Biomarker proxy tests and methods for standard blood chemistry tests

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992021368A1 (en) * 1991-06-06 1992-12-10 Life Sciences' Technologies, Inc. Composition and method for disease treatment
RU2153350C1 (ru) * 1998-11-23 2000-07-27 Закрытое акционерное общество "ВАМ" Композит гексапептида со стабилизированной дисульфидной связью с веществом металлом, фармацевтические композиции на его основе, способы их получения и применения для лечения заболеваний на основе регуляции метаболизма, пролиферации, дифференцировки и механизмов апоптоза в нормальных и патологически измененных тканях

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2178710C1 (ru) * 2001-02-08 2002-01-27 Кожемякин Леонид Андреевич Индивидуальные вещества, полученные на основе химического взаимодействия дисульфидсодержащих пептидов с производными пуриновых или пиримидиновых оснований, фармацевтические композиции и препараты на их основе, способы их применения для лечения инфекционных заболеваний и профилактики осложнений

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992021368A1 (en) * 1991-06-06 1992-12-10 Life Sciences' Technologies, Inc. Composition and method for disease treatment
RU2153350C1 (ru) * 1998-11-23 2000-07-27 Закрытое акционерное общество "ВАМ" Композит гексапептида со стабилизированной дисульфидной связью с веществом металлом, фармацевтические композиции на его основе, способы их получения и применения для лечения заболеваний на основе регуляции метаболизма, пролиферации, дифференцировки и механизмов апоптоза в нормальных и патологически измененных тканях
US7169412B2 (en) * 1998-11-23 2007-01-30 Novelos Therapeutics, Inc. Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KORIK E.O. ET AL.: "Okislitelnoe povrezhdenie glutation S-transferaz pechenikrys pri vzaimodeistvii s mediu i bilirubinom.", VESTNIK BGU. SER. 2, 2008, pages 42 - 47 *

Also Published As

Publication number Publication date
WO2013100822A2 (ru) 2013-07-04
RU2482869C1 (ru) 2013-05-27

Similar Documents

Publication Publication Date Title
WO2014002051A3 (en) Complement pathway modulators and uses thereof
WO2014002058A3 (en) Complement pathway modulators and uses thereof
ZA201405101B (en) "new indolizine compounds, a process for their preparation and pharmaceutical compositions containing them."
CA2830549C (en) Methods and compositions for preparing noribogaine from voacangine
PL2791093T3 (pl) Sposób wytwarzania 2,3,3,3-tetrafluoropropenu
WO2014009833A3 (en) Complement pathway modulators and uses thereof
UA110983C2 (ru) Производная 1,2,3,4-тетрагидрохинолина, пригодная для лечения диабета
WO2013055684A8 (en) Rasagiline citramide
WO2011157722A3 (en) Solid ivabradine-containing composition
SG11201402607VA (en) Method for purifying 1,3-butadiene
WO2012103810A1 (en) Certain chemical entities, compositions, and methods
HK1206938A1 (en) Process for the preparation of 3-chloro-4,5,6-trifluoro- picolinonitrile 3--456--
WO2013055687A3 (en) R(+)-n-formyl-propargyl-aminoindan
IL245849A0 (en) A process for making a radioactive isotope of gallium
WO2012118308A3 (ko) 피라졸 유도체를 포함하는 심혈관 질환 예방 및 치료용 조성물.
WO2012017448A3 (en) Salts of lapatinib
WO2012170720A3 (en) Methods and compositions for treating brain cancer
WO2012140490A3 (en) Processes for preparing pitavastatin calcium
WO2013121279A3 (en) Process to prepare ertapenem
WO2012155226A8 (pt) Processo para a produção de derivados de pyrostegia venusta, derivados de pyrostegia venusta, composições farmacêuticas e seus usos
WO2013100822A3 (ru) Гемостимулирующее средство
IL230907A0 (en) Salt and formations of a pyrazolopyrimidine compound, a medical composition that includes the above, and a preparation and use process for them
HK1189012A1 (en) Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
EP2862573A4 (en) COMPOSITION FOR THE TREATMENT OR PROPHYLAXIS OF VASER SPERMABILITY-RELATED DISEASES WITH IMATINIB OR PHARMACEUTICAL ACCEPTABLE SALT AS AN ACTIVE SUBSTANCE
WO2013062332A3 (ko) 시링가레시놀을 포함하는 혈관 노화 억제용 조성물

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 12861074

Country of ref document: EP

Kind code of ref document: A2